메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Tencent Cloud Hackathon Concluded with 17 Groundbreaking "AI for Social Good" Projects Developed in 48 Hours

[ 메디채널 김갑성 기자 ] Global developers unite at inaugural event, leveraging Tencent Cloud's AI tools to drive social innovation in biodiversity and mental health SHENZHEN, China, Sept. 24, 2025 -- The inaugural Tencent Cloud Hackathon Global Roadshow Day, held alongside the 2025 Tencent Global Digital Ecosystem Summit, concluded successfully in Shenzhen. Over 48 hours, 17 teams comprising 46 developers collaborated intensely to build 17 innovative "AI for Social Good" projects, showcasing how technology can drive meaningful social impact. In partnership with Tence
- 김갑성 기자
- 2025-09-24 16:36
GCCL and Frontage Laboratories Announce Strategic Collaboration to Strengthen Global Clinical Trial Capabilities

YONGIN, South Korea, Sept. 24, 2025 -- GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, and Frontage Laboratories, Inc., a USA based full-service contract research organization (CRO), announced on September 23 that they had signed a strategic Memorandum of Understanding (MOU) pursuant to which they intend to explore ways to strengthen their presence in the global clinical trial market. In signing the MOU, GCCL and Frontage intend to consider opportunities to leverage the complementary services and networks
- 김갑성 기자
- 2025-09-24 13:29
Demand for charitable services is increasing around the world, according to new Charities Aid Foundation research

LONDON, Sept. 24, 2025 -- Charities around the world say that demand for their organisation's services has increased over the last year, according to new global research by the Charities Aid Foundation (CAF). CAF's World Giving Report: Charity Insights explores the global trends and challenges for over 3,000 charity leaders in 27 countries. The report is being launched at a side event at the United Nations General Assembly in New York and follows the publication of World Giving Report: Donor Insights earlier this year. Nearly four in five (78%) of charities surv
- 김갑성 기자
- 2025-09-24 13:00
Xinhua Silk Road: Guotai Haitong Securities hosts conference on biopharma and AI in E. China's Shanghai

BEIJING, Sept. 24, 2025 -- The 2025 Shanghai pioneering industries conference, hosted by Guotai Haitong Securities, was recently held in east China's Shanghai. The event also featured the 14th pharmaceutical CEO forum and the 5th artificial intelligence (AI) conference. The event brought together nearly 100 industry leaders, representatives from almost 200 listed companies and around 1,000 investors to explore cutting-edge trends and cross-sector opportunities in biopharmaceuticals and technology. Discussions centered on innovative drug research and development, advances in medi
- 김갑성 기자
- 2025-09-24 09:02
LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly

NORWALK, Conn., Sept. 24, 2025 -- Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration with Eli Lilly and Company ("Lilly") focused on advancing innovative gene therapies for Type 2 diabetes and obesity. This partnership underscores the promise of Remedium's proprietary Prometheus™ platform and the company's leadership in developing long-acting, adjustable-dose therapeutics for major unmet medical needs. This approach aims to replace
- 김갑성 기자
- 2025-09-24 00:15
TraceLink Delivers Intelligent Productivity Gains with OPUS Platform Expansion

BOSTON, Sept. 24, 2025 -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, today announced powerful new capabilities in its Orchestration Platform for Universal Solutions (OPUS) designed to unlock unprecedented productivity. These enhancements enable finance, commercial, and IT teams to radically improve agility and productivity while reducing costs through agentic orchestration of their end-to-end supply chain. The new capabilities, introduced across OPUS, Multienterprise Information Network Tower (MINT), Process Orc
- 김갑성 기자
- 2025-09-24 00:12
바이오틱스 혁신으로 여성 철분 결핍 문제 해결…3개 대륙에서 인정받아

스톡홀름, 2025년 9월 23일 -- 여성의 철분 흡수율을 높이기 위해 개발된 혁신적 헬스케어 솔루션이 유럽과 북미에 이어 아시아에서도 최고상을 수상하며 세계 무대에서 인정을 받았다. 2025년 세 개 대륙에서 이어진 이번 수상은 더 효과적이고 부작용이 적은 철분 보충제의 필요성에 대한 세계적 인식이 확산하고 있음을 보여준다. 바이오틱스 전문 기업 프로바이(Probi)가 개발한 이번 솔루션은 임상적으로 입증된 프로바이오틱스 균주 락티플란티바실러스 플란타룸(Lactiplantibacillus plantarum) 299v(LP299V®)를 포함하고 있다. LP299V®는 철분과 함께 섭취할 경우 철분 흡수율을 높이고, 기존 보충제에서 흔히 나타나는 위장관 부작용을 줄여준다. 철분 결핍은 전 세계 가임기 여성의 30% 이상이 겪는 가장 시급한 영양 문제 중 하나다. 프로바이의 특허 균주는 단순히 철분을 보충하는 데 그치지 않고 인체가 철분을 더욱 효과적으로 흡수하도록 돕는다. LP299V®는 두 가지 주요 방식으로 철분 흡수를 지원한다. 철분을 흡수 가능한 형태로 유지하면서 동시에 체내
- 김갑성 기자
- 2025-09-23 22:19
LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services

JOHNSON CITY, Tenn., Sept. 23, 2025 -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, announces a strategic collaboration with The Bracken Group to enhance its radiopharmaceutical support capabilities. As demand for radiopharmaceutical expertise continues to surge, with industry growth estimated between 15% and 20% annually, this collaboration positions LabConnect to better serve biotech and pharmaceutical clients advancing targeted treatments and diagnostics. The Bracken Group (Bracken) is widely recognized for its
- 김갑성 기자
- 2025-09-23 21:15
Kemin Industries Acquires CJ Bio Subsidiary CJ Youtell Biotech

Specializing in enzymes and fermentation, the biotech company will transform the expansion of Kemin's global enzyme production capabilities DES MOINES, Iowa and SHANGHAI, Sept. 23, 2025 -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, is pleased to announce its acquisition of CJ Youtell Biotech, the enzymes and fermentation subsidiary of CJ Bio. This strategic move strengthens Kemin's position as a global leader in enzyme innovation for markets su
- 김갑성 기자
- 2025-09-23 21:00
Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions

CARLSBAD, Calif., Sept. 23, 2025 -- Pictor Holdings Inc., a global leader in targeted, multiplex proteomics, today announced the close of a convertible note funding round led by existing investors. The raise underscores strong confidence in Pictor's strategic expansion and recent establishment of its U.S. headquarters in Carlsbad, California. The convertible note funding represents a significant milestone in Pictor's growth trajectory and will serve as a bridge to the company's upcoming Series A funding round. Lead investor Marko Bogoievski commented, "I am proud to suppor
- 김갑성 기자
- 2025-09-23 21:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 03시 20분